Status:
UNKNOWN
Extracorporeal Shockwave Therapy (ESWT) to Improve Function in Chronic ASIA-A Patients
Lead Sponsor:
AUVA Trauma Center Meidling
Conditions:
Spinal Cord Injuries
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The global prevalence of spinal cord injury is estimated between 236 to 4187/Million. A spontaneous recovery of the sense-motoric function is decreasing with the time after injury and is only seen spo...
Eligibility Criteria
Inclusion
- patients with a spinal cord injury classified as ASIA A between the level of THII to THX (complete central lesion)
- at least 1 year after trauma
- no signs of spontaneous recovery over the last 6 months
- signed informed consent
Exclusion
- central therapies over the last 6 months (eg stem cells, electro-therapy)
- Baclofen pump
- Joint contraction lower limb \> 40° (hip or knee)
- Body weight \> 135 kg
- Body height \> 202 cm
- non-compliant patients
- Decubital ulcers at grade II or higher
- participation in an other clinical trial within the last 6 months
- Co-morbidities which make study completion doubtful or impossible
- Additional neurological diseases which may lead to further damage to the nerval system
- Malignant tumor
Key Trial Info
Start Date :
March 26 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03399968
Start Date
March 26 2015
End Date
May 31 2020
Last Update
July 5 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
AUVA Rehabilitation Center Weisser Hof
Klosterneuburg, Lower Austria, Austria, 3400
2
AUVA Rehabilitation Center Tobelbad
Haselsdorf, Styria, Austria, 8144